The U.S. Senate Committee on Health, Education Labor & Pensions held a hearing today on why the United States pays “by Far, the Highest Prices in the World for Prescription Drugs.” Patents came up throughout the hearing as one barrier to lowering prescription drug prices, while pharmaceutical industry representatives underscored the cost of bringing innovative and life-saving drugs to market and the superior access Americans have to such drugs compared with other countries.
Recent Posts
- The Outlook for SEPs in 2025: Anti-Suit Injunctions, DOJ Policy and GenAI
- Can State Law Contracts Limit the Right to Repair Even When Patent Protections Exhaust?
- Scarcity or Abundance Mindset? How Scarcity-Minded Leaders Undermine Team Culture and Potential
- ParkerVision v. Rule 36 | Patently Strategic Podcast
- Treading Carefully: How to Navigate the Common Law Research Exemption and the Hatch-Waxman Safe Harbor